This inventor holds 3 USPTO granted patents. Top assignees: Wyeth, University of Pennsylvania. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,309 
1 out of 2,659 
Years Active: 2011-2013
Title: The Innovative Contributions of Inventor William Kelley
Introduction: William Kelley, a prominent inventor based in Reading, MA, has significantly impacted the field of biomedical innovation with his groundbreaking work. With three patents to his name, Kelley has focused on developing novel therapeutic approaches utilizing antagonist antibodies against growth differentiation factor-8 (GDF-8).
Latest Patents: Kelley's latest patents include methodologies for treating muscular dystrophy through the use of antagonist antibodies against GDF-8. These patents describe the development of mouse and humanized antibodies and antibody fragments that effectively inhibit GDF-8 activity and signaling both in vitro and in vivo. His work provides new methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative disorders of muscle, bone, and insulin metabolism, with a special emphasis on conditions such as amyotrophic lateral sclerosis (ALS). Furthermore, the disclosures feature pharmaceutical compositions that utilize these antibodies, polypeptides, polynucleotides, and vectors for therapeutic purposes.
Career Highlights: Throughout his career, Kelley has contributed to significant advancements in healthcare and has collaborated with leading organizations. Among these, he has worked at Wyeth and the University of Pennsylvania, where his research has influenced various biomedical applications and therapeutic strategies.
Collaborations: Kelley's collaborations with notable professionals in the field include work alongside Frank S. Walsh and Margaret Maria Zaleska. These partnerships have fueled innovative discoveries and propelled advancements in treatments for debilitating disorders.
Conclusion: William Kelley's inventive spirit and dedication to improving health outcomes illustrate his essential role in the development of innovative therapeutic strategies targeting muscular dystrophy and related disorders. His contributions reflect the power of collaboration and research in uncovering solutions to complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile